Smartleaf Asset Management’s MBX Biosciences MBX Stock Holding History

Smartleaf Asset Management’s Portfolio MBX Stock Details MBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.16K	Buy	+20	New	+$1.25K	﹤0.01%	3165

Other funds holding MBX

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

NVP Associates Menlo Park, California $282M AUM 85.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return

Smartleaf Asset Management's MBX Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in MBX Biosciences (MBX) in Q3 2026: 20 shares worth $1.16K. The stake represents ﹤0.01% of the portfolio and ranks #3165 among its holdings.

130 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

Smartleaf Asset Management held 20 shares of MBX Biosciences worth $1.16K as of Q3 2026.
MBX Biosciences was a new Smartleaf Asset Management position in Q3 2026.
MBX Biosciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3165 holding.
130 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.